Adenosine A2A Receptor Antagonists in Parkinson’s Disease: Progress in Clinical Trials from the Newly Approved Istradefylline to Drugs in Early Development and Those Already Discontinued

CNS Drugs ◽  
2014 ◽  
Vol 28 (5) ◽  
pp. 455-474 ◽  
Author(s):  
Annalisa Pinna
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Clinical Trials ◽  
Early Development ◽  
Adenosine A2a Receptor ◽  
Receptor Antagonists ◽  
Disease Progress ◽  
Adenosine A2a Receptor Antagonists ◽  
A2a Receptor ◽  
Adenosine A2a

New adenosine A2A receptor antagonists: Actions on Parkinson's disease models

2005 ◽  
Vol 512 (2-3) ◽  
pp. 157-164 ◽  
Author(s):  
Annalisa Pinna ◽  
Rosaria Volpini ◽  
Gloria Cristalli ◽  
Micaela Morelli
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Adenosine A2a Receptor ◽  
Disease Models ◽  
Receptor Antagonists ◽  
Adenosine A2a Receptor Antagonists ◽  
A2a Receptor ◽  
Adenosine A2a
Sign in / Sign up

Export Citation Format

Share Document